WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'2201 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 9'1841 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 6'725  6'639  6'553  6'466  6'379  5'303  4'214  3'181 
Births 141  140  140  140  139  143  141  117 
Surviving infants 137  137  136  136  135  138  135  111 
Pop. less than 5 years 672  674  675  680  684  705  654  508 
Pop. less than 15 years 1'999  2'001  2'003  2'011  2'020  2'027  1'738  1'352 
Female 15-49 years 1'762  1'734  1'706  1'676  1'645  1'286  980  720 

Number of reported cases

(Click for retrospective incidence data for Paraguay)
Diphtheria
ChartChart
  10  14 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  1'396  745 
Mumps
ChartChart
  286  178  147  172  247  527 
Pertussis
ChartChart
  31  32  101  81  44  24  115  652 
Polio*
ChartChart
 
Rubella
ChartChart
  96 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  38  99 
Tetanus (total)**
ChartChart
  13  50  188 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Paraguay)
Vaccine year result method % card seen                                                
BCG          82  84  77  72  75  79  92  31 
DTP1          82  84  78  73  76  73 
DTP3          93  80  74  73  74  80  80  17 
DTP4          69  64  61 
IPV1          83 
HepB_BD          78 
HepB3          80  80  74  73  74 
Hib3          80  80  74  73  74 
JapEnc         
MCV1          91  66  72  75  74  92  71  19 
MCV2          75  60  64  64  62 
MenA         
PCV1          83  84  78  73  99 
PCV2          83  81  76  74  75 
PCV3          85  75  71  81  82 
Pol3          80  80  74  71  74  73  78  13 
Rota1          81  83  75  71  74 
RotaC          79  79  72  70  71 
RCV1          91  66  73  75  74 
TT2plus 1997  93  MCH     29  33  55  29 
PAB         
VAD1         
YFV          80  71  63  80  34 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Paraguay)
BCG
  99  99  95  90  93  85  75  31 
DTP1
  99  99  98  93  96  95  86  40 
DTP3
  93  93  87  86  87  86  67  17 
HepB3
  93  93  87  86  87 
HepB_BD
 
Hib3
  93  93  87  86  87 
IPV1
  83 
MCV1
  99  83  89  92  91  92  69  19 
MCV2
  92  77  81  81  79 
PCV3
  99  92  88  90  82 
Pol3
  89  89  83  80  83  86  64  14 
RCV1
  99  83  89  92  91  92 
RotaC
  92  92  85  83  85 
YFV
  99  99  95  97  87 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 249  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 22
From 80 to 89% 18
From 50 to 79% 53
Less than 50% 7
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepA_Adult 1st contact; risk groups
HepA_Pediatric 15 months; Yes
HepB_Adult Yes risk groups
HepB_Pediatric births; Yes from April 2017
HIB 1st contact; Yes immunocompromized
HPV 10 years; +1, +6 months; Yes
Influenza_Adult >= 60 years; Yes adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-35 months; Yes children with chronic diseases
IPV 2 months; Yes and older for risk groups
MenACWY 1st contact; Yes risk groups
MMR 1, 4 years; Yes
OPV 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years Yes and risk groups
Rotavirus 2, 4, 6 months; Yes
Td Yes every 10 years
Tdap 10 years; Yes pregnant women and other risk groups
Varicella 15 months; Yes
YF 12 months; Yes until 59 years if not vaccinated

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2014-2018  2'014  2'014  2012-2016  2012-2016  2012-2016   
Nº of districts with microplans that include activities to raise immunization coverage number 249    245  241  240  238  238 

System performance

Total Nº districts in country number 249  250  245  241  240  238  241 
Nº districts with DTP3 coverage >=80% number 99  98  81  78  86  87  86 
% of districts with DTP3 coverage >=80% From 0 to 100% 40  39  33  32  36  37  36 
Nº districts with measles (MCV1) coverage >=95% number 74  11  24  33  27  39  37 
% of districts with MCV1 coverage >=95% From 0 to 100% 30  10  14  11  16  15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100    99  97  94 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.